World-Class Scientific Team, Management Team, And Advisory Board
Segra management consists of an extremely well-rounded group of academics, growers/breeders, sales and marketing specialists, and financial executives. The company’s Advisory Board includes leading experts in the areas of clinical research, plant science, analytical chemistry, marketing, business, and engineering.
CEO, President, Director
CPA, CA, Chief Financial Officer
Chief Marketing Officer
Dr. Sma Zobayed
Ph.D., Director Of Tissue Culture
Dr. John Brunstein
Chief Scientific Officer
Dr. Kevin Mehr
Ph.D., Vice-President Of Sales
Dr. Brian Toyota
MD, CM, MSc, FRCSC, Director
Dr. Toyota obtained his Medical Degree (MD) at McGill University, completed his neurosurgical residency at the University of Western Ontario and moved to B.C. in 1993. He began work at St. Paul’s Hospital before moving to Vancouver General Hospital (VGH) and the BC Cancer Agency (BBCA), in 1996. He was the Residency Program Director from 1995 – 2003; Co-Chair of the BCCA/Vancouver Stereotactic Radiosurgery Program from its inception in 1997 – 2013; Provincial Chair of Neuro-oncology for the BCCA 2004 – 2013 and President of the Canadian Neurosurgical Society 2012 – 2014. He is also on the editorial board of the Canadian Journal of Neurosciences and sits on the Royal College Specialty Committee for Neurosurgery and the Board of the American Association of Neurological Surgery.
Dr. Brian D. Toyota is a world-renowned medical and cancer expert, and the current Head of Neurosurgery at the University of British Columbia.
Mr. Weidling is the sole proprietor of Weid Capital, a cannabis-focused financial consulting business. Mr. Weidling has over 14 years of investment banking and advisory experience, this experience includes 6 years at Canaccord Genuity as the Principal Institutional Equity Sales providing sales coverage to over 30 institution asset managers and hedge funds in New York, New Jersey and Connecticut and 4 years at Prudential Equity Group as Associate VP – Institutional Equity Sales. Prior to forming Weid Capital, Mr. Weidling consulted on or helped finance multiple cannabis businesses in the U.S. and Canada, including over two years as the CFO of Theraplant in Connecticut.
Dr. Kevin She
BA, MSc., Ph.D., Quality Assurance Manager/Senior Scientist
Dr. She has a diverse background including industrial microbiology for the discovery of novel antibiotics, extensive expertise in mammalian tissue and cell culture, and industrial experience in writing and implementing SOPs for products intended for use in the clinical setting. During his grant funded industrial postdoctoral fellowship, Dr. She has written SOPs for the use, production, quality control, test validation, and real-time product stability testing for molecular diagnostic kits intended for use in the clinical setting. In addition to implementing these SOPs, he has also trained and supervised others in the adherence to these protocols. Throughout his career, Dr. She has acquired a strong academic publishing portfolio and contributed to successful C17 and NIH R01 grants, among others, and has personally been awarded MSFHR, a prestigious CIHR CGS, and NSERC grants.
Ms. Thomson has 20 years of experience in the securities market including 12 years direct experience acting as an officer and or director providing corporate secretary services to listed companies. This experience includes working with highly active and successful companies listed on the TSX, TSX.V, NYSE and the Alternative Investment Market of the London Stock Exchange.
Molecular Biology Lab Manager
Ms. Ng obtained her B.Sc. in Molecular Biology and Biochemistry from Simon Fraser University, followed by the Registered Technologist (CSMLS) program in Clinical Genetics from the British Columbia Institute of Technology. Working at BC Provincial Health Services Authority (PHSA) for over 12 years, she started as a clinical molecular and cytogenetics technologist. In 2011, she obtained formal certification in biobanking and led the biobanking efforts for the BC Cancer Agency and Vancouver General Hospital. In 2013 she completed her M.A. in Leadership from Trinity Western University. Most recently prior to joining Segra, her role in PHSA was as a lab manager where she oversaw facility planning of laboratory space, acquired capital equipment, and ensured proper resourcing of multiple projects.
Senior Tissue Culture Specialist
Ms. Kaur is a highly technical and efficient tissue culture specialist who has studied under the tutelage of Dr. Zobayed for the past five years. She received her Diploma in Production Horticulture in 2015 from Kwantlen Polytechnic University. From there she achieved her Certification on Photoautotrophic Tissue Culture from the Faculty of Horticulture at Chiba University in Japan and Certification on Micropropagation Techniques from Nerang MDC in Australia. She began her career in 2011 as a Quality Control Technician at Lally Farms in Abbotsford, BC, and was then hired at JRT Nurseries, in Aldergrove, BC, as the Plant Tissue Culture Supervisor. She has held positions of increasing responsibility at JRT Nurseries, where she most recently held the position of Assistant Manager for the Tissue Culture Labs in Washington State and BC, that have a maximum output of 12 million plants a year for over 500 different plant species.
PMP, MSc., Project Manager
Mr. Zaiets joined Segra in August of 2018 with extensive project management experience. He earned his Master’s Degree in Nuclear Engineering from the National Technical University of Ukraine, obtained his Business Management Diploma from BCIT, and currently holds a PMP designation. Prior to joining Segra, he was with ENCO involved in managing large-scale international projects related to nuclear safety and radioactive waste management.